Rapid_NP Detection_NP of_IN Methicillin_NP Resistance_NP in_IN Coagulase-Negative_NP Staphylococci_NP with_IN the_DT VITEK_NP 2_CD System_NN The_DT aim_NN of_IN the_DT present_JJ study_NN was_VBD to_TO evaluate_VB the_DT accuracy_NN of_IN the_DT new_JJ VITEK_NP 2_CD system_NN (_( bioMerieux_NP ,_, Marcy_NP l_NN '_POS Etoile_NP ,_, France_NP )_) for_IN the_DT detection_NN of_IN methicillin_NN resistance_NN in_IN coagulase-negative_JJ staphylococci_NNS (_( CoNS_NP )_) by_IN using_VBG AST-P515_NP and_CC AST-P523_NP test_NN cards_NNS ._SENT Analyses_NNS of_IN the_DT VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN evaluated_VBD according_VBG to_TO the_DT actual_JJ breakpoint_NN (_( >=0.5_JJ mug/ml_NN )_) of_IN the_DT National_NP Committee_NP for_IN Clinical_NP Laboratory_NP Standards_NPS resulted_VBD in_IN a_DT high_JJ sensitivity_NN of_IN 99.2_CD %_NN but_CC a_DT moderate_JJ specificity_NN of_IN 80_CD %_NN ._SENT The_DT newly_RB included_VBN oxacillin_NN resistance_NN (_( OR_JJ )_) test_NN of_IN the_DT VITEK_NP 2_CD system_NN displayed_VBD a_DT high_JJ sensitivity_NN and_CC a_DT high_JJ specificity_NN of_IN 97.5_CD and_CC 98.7_CD %_NN ,_, respectively_RB ._SENT Concordance_NN between_IN the_DT results_NNS of_IN the_DT mecA_NP PCR_NP and_CC the_DT VITEK_NP 2_CD oxacillin_NN MIC_NN was_VBD observed_VBN for_IN almost_RB all_DT Staphylococcus_NP epidermidis_NN strains_NNS ,_, but_CC the_DT reduced_VBN specificity_NN was_VBD attributable_JJ to_TO higher_JJR oxacillin_NN MICs_NNS for_IN mecA-negative_JJ non-S_NNS ._SENT epidermidis_NNS strains_NNS ,_, especially_RB S._NP saprophyticus_NN ,_, S._NP lugdunensis_NN ,_, and_CC S._NP cohnii_NP ._SENT Evaluation_NN of_IN alternative_JJ oxacillin_NN MIC_JJ breakpoints_NNS of_IN 1_CD ,_, 2_CD ,_, or_CC 4_CD mug/ml_NN resulted_VBN in_IN improved_VBN degrees_NNS of_IN specificity_NN of_IN 84_CD ,_, 90.7_CD ,_, and_CC 97.3_CD %_NN ,_, respectively_RB ._SENT Only_JJ minor_JJ changes_NNS occurred_VBN in_IN the_DT corresponding_JJ sensitivity_NN values_NNS ,_, which_WDT were_VBD 98.4_CD ,_, 97.5_CD ,_, and_CC 97.5_CD %_NN ,_, respectively_RB ._SENT Methicillin_NN resistance_NN in_IN CoNS_NP was_VBD detected_VBN after_IN 7_CD and_CC 8_CD h_NN in_IN 91.1_CD and_CC 93.5_CD %_NN of_IN the_DT mecA-positive_JJ strains_NNS ,_, respectively_RB ,_, by_IN the_DT VITEK_NP 2_CD OR_NN test_NN and_CC in_IN 86.3_CD and_CC 89.5_CD %_NN of_IN the_DT mecA-positive_JJ strains_NNS ,_, respectively_RB ,_, by_IN VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN ._SENT After_IN 7_CD and_CC 8_CD h_NN the_DT VITEK_NP 2_CD OR_NN test_NN classified_VBN 59.2_CD and_CC 78.9_CD %_NN of_IN the_DT mecA-negative_JJ strains_NNS ,_, respectively_RB ,_, as_RB susceptible_JJ to_TO oxacillin_NN ,_, whereas_IN comparable_JJ values_NNS were_VBD obtained_VBN 2_CD h_NN later_RBR by_IN VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN ._SENT The_DT results_NNS of_IN our_PP$ study_NN encourage_VB the_DT use_NN of_IN the_DT VITEK_NP 2_CD system_NN ,_, which_WDT proved_VBD to_TO be_VB a_DT highly_RB reliable_JJ and_CC rapid_JJ phenotypic_JJ method_NN for_IN the_DT detection_NN of_IN methicillin_NN resistance_NN in_IN CoNS_NP ._SENT Coagulase-negative_JJ staphylococci_NNS (_( CoNS_NP )_) rank_NN among_IN the_DT five_CD most_RBS frequent_JJ causative_JJ organisms_NNS of_IN nosocomial_JJ infections_NNS ,_, which_WDT are_VBP regularly_RB associated_VBN with_IN biomedical_JJ implants_NNS ._SENT Antibiotic_JJ therapy_NN of_IN infections_NNS caused_VBN by_IN CoNS_NP is_VBZ increasingly_RB problematic_JJ due_RB to_TO frequent_JJ multiple-antibiotic_JJ resistance_NN ._SENT Most_RBS importantly_RB ,_, the_DT majority_NN of_IN clinical_JJ CoNS_NNS harbor_VBP the_DT mecA_NN gene_NN encoding_VBG an_DT additional_JJ penicillin_NN binding_VBG protein_NN (_( PBP_NP )_) 2a_NP (_( PBP_NP 2a_NP )_) ._SENT Phenotypic_JJ detection_NN of_IN methicillin_NN resistance_NN in_IN CoNS_NP is_VBZ difficult_JJ due_RB to_TO the_DT heterogeneous_JJ expression_NN of_IN mecA_NN ._SENT Detection_NN of_IN mecA_NN by_IN PCR_NP is_VBZ very_RB sensitive_JJ and_CC is_VBZ considered_VBN the_DT "_`` gold_JJ standard_NN ,_, "_`` but_CC it_PP is_VBZ not_RB feasible_JJ for_IN the_DT busy_JJ clinical_JJ microbiology_NN laboratory_NN ._SENT Detection_NN of_IN PBP_NP 2a_NP as_IN a_DT marker_NN for_IN methicillin_NN resistance_NN in_IN CoNS_NP is_VBZ also_RB rapid_JJ and_CC reliable_JJ and_CC has_VBZ therefore_RB been_VBN recommended_VBN as_IN an_DT alternative_NN for_IN mecA_NP PCR_NP by_IN the_DT National_NP Committee_NP for_IN Clinical_NP Laboratory_NP Standards_NP (_( NCCLS_NP )_) ._SENT The_DT VITEK_NP 2_CD system_NN (_( bioMerieux_NP ,_, Marcy_NP l'Etoile_NP ,_, France_NP )_) is_VBZ a_DT fully_RB automated_VBN system_NN for_IN rapid_JJ identification_NN and_CC antimicrobial_JJ susceptibility_NN testing_NN and_CC is_VBZ reliable_JJ for_IN many_DT rapidly_RB growing_JJ bacteria_NNS (_( ,_, -_: ,_, ,_, ,_, ,_, -_: ,_, ,_, ,_, ,_, )_) and_CC yeasts_NNS ._SENT In_IN the_DT earlier_JJR generation_NN of_IN the_DT system_NN ,_, the_DT Vitek_NP system_NN ,_, detection_NN of_IN methicillin_NN resistance_NN was_VBD solely_RB based_VBN on_IN oxacillin_NN MIC_JJ determination_NN ._SENT To_TO enhance_VB the_DT sensitivity_NN and_CC the_DT specificity_NN of_IN the_DT system_NN ,_, an_DT oxacillin_NN resistance_NN (_( OR_JJ )_) test_NN was_VBD introduced_VBN into_IN the_DT new_JJ VITEK_NP 2_CD system_NN as_IN a_DT second_JJ assay_NN ._SENT The_DT composition_NN of_IN the_DT VITEK_NP 2_CD OR_NN test_NN is_VBZ comparable_JJ to_TO that_DT of_IN the_DT oxacillin_NN agar_NN screen_NN ._SENT Recently_RB ,_, detection_NN of_IN methicillin_NN resistance_NN in_IN Staphylococcus_NP aureus_NN with_IN the_DT VITEK_NP 2_CD system_NN was_VBD investigated_VBN ,_, but_CC detection_NN of_IN methicillin_NN resistance_NN in_IN clinical_JJ CoNS_NP isolates_NNS has_VBZ not_RB been_VBN studied_VBN in_IN detail_NN ._SENT In_IN the_DT present_JJ study_NN detection_NN of_IN mecA_NN by_IN PCR_NP was_VBD compared_VBN to_TO the_DT results_NNS of_IN the_DT OR_JJ test_NN and_CC oxacillin_NN MIC_JJ determination_NN with_IN the_DT VITEK_NP 2_CD system_NN for_IN 200_CD isolates_NNS of_IN CoNS_NP ._SENT The_DT time_NN until_IN detection_NN of_IN methicillin_NN resistance_NN was_VBD analyzed_VBN for_IN both_DT tests_NNS in_IN parallel_NN ._SENT (_( Part_NN of_IN this_DT work_NN will_MD appear_VB in_IN the_DT doctoral_JJ thesis_NN of_IN M.A.H._NP ,_, Universitatsklinikum_NP Hamburg-Eppendorf_NP ,_, Hamburg_NP ,_, Germany_NP ._SENT )_) Bacterial_NP isolates_VBZ ._SENT |_SYM The_DT CoNS_NP strains_NNS (_( n_NN =_SYM 200_LS )_) belong_VB to_TO a_DT collection_NN of_IN clinical_JJ isolates_NNS which_WDT were_VBD consecutively_RB collected_VBN at_IN the_DT University_NP Hospital_NP Hamburg-Eppendorf_NP in_IN 1997_CD and_CC 1998_CD and_CC include_VBP 13_CD different_JJ species_NNS (_( 140_CD S._NP epidermidis_NNS ,_, 16_CD S._NP haemolyticus_NN ,_, 10_CD S._NP hominis_NNS ,_, 9_CD S._NP saprophyticus_NN ,_, 6_CD S._NP capitis_NN ,_, 4_CD S._NP lugdunensis_NN ,_, 4_CD S._NP warneri_NP ,_, 4_CD S._NP xylosus_NN ,_, 2_CD S._NP schleiferi_NP ,_, 2_CD S._NP cohnii_NP ,_, 1_CD S._NP chromogenes_NNS ,_, 1_CD S._NP simulans_NNS ,_, and_CC 1_CD S._NP kloosii_NN isolates_NNS )_) ,_, as_RB described_VBN previously_RB ._SENT S._NP aureus_NN ATCC_NP 29213_CD (_( mecA_NN negative_NN )_) and_CC S._NP aureus_NN ATCC_NP 43300_CD (_( mecA_NN positive_NN )_) were_VBD used_VBN for_IN quality_NN control_NN ._SENT The_DT strains_NNS were_VBD kept_VBN at_IN -80C_NN in_IN microbank_NN tubes_NNS (_( Pro_NP Lab_NP Diagnostics_NP ,_, Richmond_NP Hill_NP ,_, Ontario_NP ,_, Canada_NP )_) and_CC were_VBD subcultured_VBN twice_RB onto_IN Columbia_NP agar_NN (_( Difco_NP ,_, Becton_NP Dickinson_NP ,_, Sparks_NP ,_, Md._NP )_) plates_NNS containing_VBG 5_CD %_NN sheep_NN blood_NN in_IN ambient_JJ air_NN at_IN 37C_JJ before_IN testing_NN ._SENT Antimicrobial_JJ susceptibility_NN testing_NN with_IN the_DT VITEK_NP 2_CD system_NN ._SENT |_SYM The_DT phenotypes_NNS of_IN the_DT strains_NNS were_VBD determined_VBN by_IN detection_NN of_IN methicillin_NN resistance_NN by_IN the_DT oxacillin_NN resistance_NN (_( OR_JJ )_) test_NN (_( categories_NNS of_IN susceptible_JJ or_CC resistant_JJ )_) and_CC oxacillin_NN MIC_JJ determination_NN ._SENT Both_DT tests_NNS are_VBP included_VBN in_IN the_DT AST-P515_NP antimicrobial_JJ susceptibility_NN test_NN cards_NNS and_CC in_IN the_DT newer_JJR AST-P523_NP antimicrobial_JJ susceptibility_NN test_NN cards_NNS ._SENT The_DT AST-P523_NP cards_NNS differ_VBP from_IN the_DT AST-P515_NP cards_NNS only_RB in_IN their_PP$ lower_JJR oxacillin_NN MIC_JJ range_NN (_( <=0.25_to =4_JJ mug/ml_NN versus_CC <=0.5_to =8_NN mug/ml_NN )_) and_CC not_RB in_IN the_DT composition_NN of_IN the_DT tests_NNS examined_VBD ._SENT The_DT instructions_NNS of_IN the_DT manufacturer_NN for_IN antibiotic_JJ susceptibility_NN testing_NN with_IN the_DT VITEK_NP 2_CD system_NN were_VBD essentially_RB followed_VBN ._SENT Reading_VBG of_IN test_NN cards_NNS was_VBD performed_VBN every_DT 15_CD min_NN by_IN the_DT VITEK_NP 2_CD system_NN ,_, and_CC the_DT results_NNS for_IN the_DT VITEK_NP 2_CD OR_NN test_NN and_CC the_DT VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN were_VBD recorded_VBN after_IN every_DT reading_NN for_IN up_IN to_TO 10_CD h_NN for_IN each_DT isolate_NN ._SENT Initially_RB ,_, all_DT CoNS_NP isolates_NNS were_VBD tested_VBN with_IN AST-P515_NP cards_NNS ._SENT CoNS_NNS strains_NNS for_IN which_WDT the_DT VITEK_NP 2_CD oxacillin_NN MIC_NN was_VBD <=0.5_JJ mug/ml_NN were_VBD additionally_RB tested_VBN with_IN the_DT AST-P523_NP card_NN ,_, allowing_VBG determination_NN of_IN lower_JJR oxacillin_NN MICs_NNS ._SENT CoNS_NNS isolates_NNS with_IN discrepancies_NNS between_IN the_DT results_NNS of_IN the_DT PCR_NP for_IN mecA_NP and_CC the_DT VITEK_NP 2_CD tests_NNS were_VBD reexamined_VBN ._SENT If_IN an_DT initial_JJ oxacillin_NN MIC_NN of_IN <=0.5_or =2_JJ mug/ml_NN ._SENT On_IN retesting_VBG the_DT same_JJ procedure_NN was_VBD used_VBN as_IN described_VBN above_IN ,_, and_CC neither_DT method_NN was_VBD voluntarily_RB changed_VBN ._SENT PCR_NP for_IN mecA_NP ._SENT |_SYM PCRs_NN were_VBD performed_VBN essentially_RB as_RB described_VBN previously_RB ._SENT MecA_NP was_VBD detected_VBN in_IN 124_CD of_IN 200_CD (_( 62_CD %_NN )_) strains_NNS comprising_VBG 99_CD of_IN 140_CD (_( 70.7_CD %_NN )_) mecA-positive_JJ S._NP epidermidis_NNS strains_NNS and_CC 25_CD of_IN 60_CD (_( 41.7_CD %_NN )_) mecA-positive_JJ non-S_NNS ._SENT epidermidis_NNS strains_NNS ._SENT The_DT VITEK_NP 2_CD oxacillin_NN MIC_NN was_VBD >=8_JJ mug/ml_NN for_IN 119_CD of_IN 124_CD mecA-positive_JJ strains_NNS ._SENT Lower_JJR VITEK_NP 2_CD oxacillin_NN MICs_NNS ranging_VBG from_IN <=0.25_NN to_TO 2_CD mug/ml_NN were_VBD found_VBN for_IN three_CD mecA-positive_JJ strains_NNS (_( one_CD S._NP epidermidis_NNS strain_NN ,_, one_CD S._NP hominis_NNS strain_NN ,_, and_CC one_CD S._NP haemolyticus_NN strain_NN (_( Tables_NP and_CC )_) ._SENT With_IN the_DT AST-P515_NP cards_NNS ,_, for_IN 63_CD of_IN 76_CD mecA-negative_JJ strains_NNS the_DT oxacillin_NN MIC_NN was_VBD <=0.5_mug/ml =8_JJ mug/ml_NN ._SENT The_DT 63_CD strains_NNS for_IN which_WDT the_DT initial_JJ VITEK_NP 2_CD oxacillin_NN MIC_NN was_VBD <=0.5_JJ mug/ml_NN with_IN the_DT AST-P515_NP cards_NNS were_VBD additionally_RB tested_VBN with_IN AST-P523_NP cards_NNS ._SENT An_DT oxacillin_NN MIC_NN of_IN <=0.25_JJ mug/ml_NN was_VBD detected_VBN for_IN 60_CD strains_NNS ,_, but_CC for_IN 3_CD mecA-negative_JJ strains_NNS (_( 1_CD S._NP saprophyticus_NN strain_NN and_CC 2_CD S._NP lugdunensis_NN strains_NNS )_) the_DT oxacillin_NN MIC_NN was_VBD 0.5_CD mug/ml_NN (_( Tables_NP and_CC )_) ._SENT The_DT VITEK_NP 2_CD OR_NN test_NN with_IN the_DT AST-P515_NP card_NN detected_VBD 119_CD of_IN 124_CD mecA-positive_JJ strains_NNS but_CC failed_VBD to_TO indicate_VB methicillin_NN resistance_NN in_IN the_DT 3_CD mecA-positive_JJ strains_NNS (_( 1_CD S._NP epidermidis_NNS strain_NN ,_, 1_CD S._NP hominis_NNS strain_NN ,_, and_CC 1_CD S._NP haemolyticus_NN strain_NN )_) ,_, for_IN which_WDT VITEK_NP 2_CD oxacillin_NN MICs_NNS were_VBD <=0.25_to =8_JJ mug/ml_NN ,_, were_VBD correctly_RB classified_VBN as_IN susceptible_JJ by_IN the_DT VITEK_NP 2_CD OR_NN test_NN (_( Tables_NP and_CC )_) ._SENT Discrepancies_NNS between_IN the_DT results_NNS of_IN the_DT VITEK_NP 2_CD OR_NN test_NN and_CC the_DT VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN were_VBD observed_VBN for_IN 14_CD mecA-negative_JJ strains_NNS (_( 6_CD S._NP saprophyticus_NN ,_, 4_CD S._NP lugdunensis_NN ,_, 2_CD S._NP cohnii_NP ,_, 1_CD S._NP xylosus_NN ,_, and_CC 1_CD S._NP epidermidis_NN strains_NNS )_) ,_, with_IN VITEK_NP 2_CD oxacillin_NN MICs_NNS ranging_VBG from_IN 0.5_CD to_TO 4_CD mug/ml_NN but_CC with_IN susceptibility_NN indicated_VBN by_IN the_DT VITEK_NP 2_CD OR_NN test_NN (_( Tables_NP and_CC )_) ._SENT The_DT results_NNS for_IN these_DT 14_CD strains_NNS were_VBD categorized_VBN as_IN indeterminate_JJ (_( Tables_NP and_CC )_) ._SENT Additionally_RB ,_, the_DT above-mentioned_JJ mecA-positive_JJ S._NP epidermidis_NNS (_( n_NN =_SYM 1_CD )_) and_CC mecA-positive_JJ S._NP hominis_NNS (_( n_NN =_SYM 1_LS )_) strains_NNS for_IN which_WDT the_DT VITEK_NP 2_CD oxacillin_NN MICs_NN were_VBD 1_CD and_CC 0.5_CD mug/ml_NN ,_, respectively_RB ,_, but_CC which_WDT were_VBD susceptible_JJ by_IN the_DT VITEK_NP 2_CD OR_NN test_NN were_VBD categorized_VBN as_IN indeterminate_JJ (_( Tables_NP and_CC )_) ._SENT Retesting_VBG of_IN the_DT 16_CD strains_NNS categorized_VBN as_IN indeterminate_JJ confirmed_VBD the_DT initial_JJ VITEK_NP 2_CD OR_NN test_NN result_NN for_IN all_DT strains_NNS and_CC the_DT VITEK_NP 2_CD oxacillin_NN MIC_NN did_VBD not_RB vary_VB significantly_RB ._SENT Insufficient_JJ growth_NN in_IN the_DT AST-P515_NP cards_NNS was_VBD observed_VBN for_IN three_CD strains_NNS including_VBG one_CD mecA-negative_JJ S._NP epidermidis_NNS strain_NN and_CC two_CD mecA-positive_JJ S._NP saprophyticus_NN strains_NNS ._SENT On_IN retesting_VBG of_IN these_DT strains_NNS with_IN AST-P515_NP cards_NNS ,_, one_CD mecA-positive_JJ S._NP saprophyticus_NN strain_NN again_RB did_VBD not_RB grow_VB ,_, whereas_IN susceptibility_NN to_TO oxacillin_NN was_VBD correctly_RB determined_VBN for_IN the_DT other_JJ mecA-positive_JJ S._NP saprophyticus_NN strain_NN and_CC the_DT mecA-negative_JJ S._NP epidermidis_NNS strain_NN (_( Tables_NP and_CC )_) ._SENT Neither_DT S._NP saprophyticus_NN strain_NN grew_VBD with_IN AST-P523_NP cards_NNS ._SENT Among_IN the_DT mecA-positive_JJ strains_NNS ,_, resistance_NN to_TO oxacillin_NN was_VBD detected_VBN after_IN 7_CD ,_, 8_CD ,_, and_CC 9_CD h_NN by_IN the_DT VITEK_NP 2_CD OR_NN test_NN in_IN 91.1_CD ,_, 93.5_CD ,_, and_CC 95.2_CD %_NN of_IN the_DT strains_NNS ,_, respectively_RB ,_, and_CC by_IN VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN in_IN 86.3_CD ,_, 89.5_CD ,_, and_CC 91.9_CD %_NN of_IN the_DT strains_NNS ,_, respectively_RB ._SENT However_RB ,_, among_IN the_DT mecA-negative_JJ strains_NNS ,_, susceptibility_NN to_TO oxacillin_NN was_VBD detected_VBN after_IN 7_CD ,_, 8_CD ,_, and_CC 9_CD h_NN by_IN the_DT VITEK_NP 2_CD OR_NN test_NN in_IN 59.2_CD ,_, 78.9_CD ,_, and_CC 86.8_CD %_NN of_IN the_DT strains_NNS ,_, respectively_RB ,_, and_CC by_IN VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN in_IN 0_CD ,_, 1.3_CD ,_, and_CC 59.2_CD %_NN of_IN the_DT strains_NNS ,_, respectively_RB ._SENT FIG._NN 1_CD ._SENT |_SYM Time_NP course_NN of_IN results_NNS of_IN VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN and_CC VITEK_NP 2_CD oxacillin_NN resistance_NN test_NN for_IN mecA-positive_JJ CoNS_NP strains_NNS (_( A_NP )_) and_CC mecA-negative_JJ CoNS_NP strains_NNS (_( B_NP )_) ._SENT Time_NN course_NN of_IN results_NNS of_IN VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN and_CC VITEK_NP 2_CD oxacillin_NN resistance_NN test_NN for_IN mecA-positive_JJ CoNS_NP strains_NNS (_( A_NP )_) and_CC mecA-negative_JJ CoNS_NP strains_NNS (_( B_NP )_) ._SENT TABLE_NN 1_CD |_SYM Comparison_NN of_IN the_DT oxacillin_NN MIC_JJ determination_NN and_CC the_DT OR_JJ test_NN of_IN the_DT VITEK_NP 2_CD system_NN with_IN the_DT results_NNS of_IN the_DT mecA_NP PCR_NP TABLE_NP 2_CD |_SYM Discrepant_JJ and_CC indeterminate_JJ results_NNS of_IN VITEK_NP 2_CD tests_NNS compared_VBN to_TO the_DT results_NNS of_IN the_DT mecA_NP PCR_NP In_IN the_DT Vitek_NP system_NN ,_, detection_NN of_IN methicillin_NN resistance_NN was_VBD solely_RB based_VBN on_IN oxacillin_NN MIC_JJ determination_NN ._SENT Three_CD recent_JJ studies_NNS reported_VBD high_JJ sensitivities_NNS (_( range_NN ,_, 95.7_CD to_TO 100_CD %_NN )_) but_CC only_RB a_DT moderate_JJ degree_NN of_IN specificity_NN (_( range_NN ,_, 61_CD to_TO 85.5_CD %_NN )_) for_IN the_DT Vitek_NP system_NN with_IN CoNS_NP ._SENT To_TO improve_VB the_DT rate_NN of_IN detection_NN of_IN methicillin_NN resistance_NN in_IN staphylococci_NNS ,_, the_DT OR_JJ test_NN was_VBD implemented_VBN in_IN the_DT new_JJ VITEK_NP 2_CD system_NN ._SENT Recently_RB ,_, VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN performed_VBN with_IN excellent_JJ results_NNS for_IN the_DT sensitive_JJ and_CC specific_JJ detection_NN of_IN methicillin-resistant_JJ S._NP aureus_NN ._SENT So_RB far_RB ,_, analyses_NNS of_IN methicillin_NN resistance_NN in_IN CoNS_NP have_VBP been_VBN performed_VBN with_IN only_RB a_DT small_JJ number_NN of_IN selected_JJ mecA-positive_JJ S._NP epidermidis_NNS ,_, S._NP hominis_NNS ,_, and_CC S._NP warneri_NP strains_NNS ,_, with_IN overall_JJ agreement_NN with_IN the_DT PCR_NP results_NNS ._SENT When_WRB our_PP$ study_NN was_VBD evaluated_VBN according_VBG to_TO the_DT actual_JJ NCCLS_NP oxacillin_NN breakpoint_NN of_IN >=0.5_JJ mug/ml_NN ,_, VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN correctly_RB classified_VBD 119_CD of_IN 124_CD mecA-positive_JJ CoNS_NP strains_NNS as_IN resistant_NN and_CC 60_CD of_IN 76_CD mecA-negative_JJ strains_NNS as_IN susceptible_JJ ,_, which_WDT resulted_VBD in_IN a_DT high_JJ sensitivity_NN of_IN 99.2_CD %_NN but_CC a_DT moderate_JJ specificity_NN of_IN 80_CD %_NN ._SENT When_WRB the_DT older_JJR NCCLS_NP oxacillin_NN breakpoint_NN of_IN >=4_JJ mug/ml_NN is_VBZ used_VBN in_IN the_DT evaluation_NN ,_, VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN again_RB correctly_RB classified_VBN 119_CD of_IN 124_CD mecA-positive_JJ strains_NNS as_IN resistant_NN but_CC 73_CD of_IN 76_CD mecA-negative_JJ strains_NNS as_IN susceptible_JJ ,_, resulting_VBG in_IN an_DT excellent_JJ sensitivity_NN of_IN 97.5_CD %_NN and_CC a_DT specificity_NN of_IN 97.3_CD %_NN ._SENT Calculations_NNS based_VBN on_IN oxacillin_NN MIC_JJ breakpoints_NNS of_IN 1_CD and_CC 2_CD mug/ml_NN yielded_VBD sensitivities_NNS of_IN 98.4_CD and_CC 97.5_CD %_NN ,_, respectively_RB ,_, and_CC specificities_NNS of_IN 84_CD and_CC 90.7_CD %_NN ,_, respectively_RB ._SENT Detection_NN of_IN methicillin_NN resistance_NN in_IN CoNS_NP solely_RB on_IN the_DT basis_NN of_IN the_DT results_NNS of_IN the_DT VITEK_NP 2_CD OR_NN test_NN was_VBD superior_JJ to_TO VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN ,_, with_IN a_DT sensitivity_NN of_IN 97.5_CD %_NN and_CC a_DT specificity_NN of_IN 98.7_CD %_NN ._SENT Remarkably_RB ,_, 14_CD of_IN the_DT 16_CD strains_NNS with_IN susceptibility_NN by_IN the_DT VITEK_NP 2_CD OR_NN test_NN but_CC for_IN which_WDT the_DT VITEK_NP 2_CD oxacillin_NN MIC_NN was_VBD above_IN the_DT actual_JJ NCCLS_NP breakpoint_NN were_VBD non-S_JJ ._SENT epidermidis_NNS strains_NNS ,_, consisting_VBG of_IN 6_CD S._NP saprophyticus_NN ,_, 4_CD S._NP lugdunensis_NN ,_, 2_CD S._NP cohnii_NP ,_, 1_CD S._NP xylosus_NN ,_, and_CC 1_CD S._NP hominis_NNS strains_NNS but_CC only_RB 2_CD S._NP epidermidis_NNS strains_NNS ._SENT Another_DT characteristic_JJ feature_NN of_IN strains_NNS with_IN indeterminate_JJ results_NNS is_VBZ the_DT predominance_NN of_IN novobiocin-resistant_JJ species_NNS for_IN 9_CD of_IN 16_CD strains_NNS ._SENT Only_RB 2_CD strains_NNS (_( 1_CD S._NP epidermidis_NNS strain_NN and_CC the_DT 1_CD S._NP hominis_NNS strain_NN )_) classified_VBN as_IN indeterminate_JJ were_VBD in_IN fact_NN mecA_NNS positive_JJ ,_, but_CC 14_CD of_IN 16_CD strains_NNS were_VBD mecA_RB negative_JJ (_( Table_NP and_CC )_) ._SENT Only_RB one_CD mecA-negative_JJ S._NP kloosii_NN strain_NN displayed_VBD a_DT false-positive_JJ result_NN ,_, with_IN a_DT VITEK_NP 2_CD oxacillin_NN MIC_JJ of_IN >=8_JJ mug/ml_NN and_CC resistance_NN by_IN the_DT VITEK_NP 2_CD OR_NN test_NN (_( Tables_NP and_CC )_) ._SENT The_DT molecular_JJ basis_NN of_IN decreased_VBN susceptibility_NN to_TO oxacillin_NN in_IN mecA-negative_JJ CoNS_NNS warrants_VBZ further_JJR investigations_NNS ,_, but_CC alterations_NNS in_IN PBPs_NNS other_JJ than_IN PBP_NP 2a_NP have_VBP been_VBN documented_VBN in_IN S._NP haemolyticus_NP and_CC S._NP saprophyticus_NN and_CC were_VBD suggested_VBN as_IN one_CD possible_JJ explanation_NN ._SENT A_DT false-negative_JJ result_NN was_VBD observed_VBN for_IN a_DT mecA-positive_JJ S._NP haemolyticus_NN strain_NN for_IN which_WDT the_DT VITEK_NP 2_CD oxacillin_NN MIC_NN was_VBD <=0.5_JJ mug/ml_NN (_( oxacillin_NN MIC_NN on_IN retesting_NN ,_, <=0.25_mug/ml) =0.5_JJ mug/ml_NN )_) ,_, oxacillin_NN MIC_JJ determination_NN with_IN the_DT Vitek_NP system_NN and_CC by_IN broth_NN microdilution_NN and_CC agar_NN dilution_NN would_MD have_VB classified_VBN as_IN resistant_JJ 81_CD of_IN 83_CD ,_, 76_CD of_IN 83_CD ,_, and_CC 81_CD of_IN 83_CD mecA-negative_JJ strains_NNS ,_, respectively_RB ._SENT In_IN the_DT VITEK_NP 2_CD system_NN ,_, the_DT OR_JJ test_NN leads_VBZ to_TO the_DT specific_JJ detection_NN of_IN methicillin_NN resistance_NN ;_: however_RB ,_, indeterminate_JJ results_NNS occur_VBP with_IN the_DT OR_JJ test_NN ,_, indicating_VBG sensitivity_NN ,_, and_CC VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN ,_, indicating_VBG resistance_NN ._SENT If_IN indeterminate_JJ results_NNS occur_VBP ,_, we_PP recommend_VBP that_IN the_DT results_NNS of_IN the_DT VITEK_NP 2_CD OR_NN test_NN be_VB followed_VBN ._SENT An_DT alternative_JJ strategy_NN would_MD be_VB to_TO deduce_VB susceptibility_NN to_TO oxacillin_NN from_IN the_DT species_NN identification_NN or_CC at_IN least_JJS resistance_NN to_TO novobiocin_NN because_IN we_PP observed_VBD the_DT most_RBS indeterminate_JJ results_NNS for_IN mecA-negative_JJ strains_NNS belonging_VBG to_TO the_DT S._NP saprophyticus_NN group_NN and_CC S._NP lugdunensis_NP (_( Tables_NP and_CC )_) ._SENT More_JJR isolates_NNS of_IN the_DT respective_JJ species_NN must_MD be_VB analyzed_VBN to_TO reach_VB generalized_VBN conclusions_NNS ,_, but_CC recently_RB ,_, the_DT NCCLS_NP has_VBZ also_RB emphasized_VBN that_IN the_DT current_JJ interpretative_JJ criteria_NNS for_IN the_DT oxacillin_NN MIC_NN could_MD be_VB misleading_VBG ,_, especially_RB for_IN S._NP saprophyticus_NP and_CC S._NP lugdunensis_NN strains_NNS ._SENT The_DT VITEK_NP 2_CD system_NN rapidly_RB reported_VBD the_DT resistance_NN results_NNS obtained_VBN by_IN oxacillin_NN MIC_JJ determination_NN and_CC the_DT OR_JJ test_NN :_: after_IN 8_CD h_NN for_IN about_RB 80_CD %_NN of_IN the_DT strains_NNS ._SENT Compared_VBN to_TO conventional_JJ phenotypic_JJ methods_NNS ,_, which_WDT would_MD take_VB up_RP to_TO 48_CD h_NN ,_, this_DT substantial_JJ acceleration_NN of_IN the_DT diagnostic_JJ capability_NN with_IN the_DT VITEK_NP 2_CD system_NN may_MD have_VB a_DT potential_JJ impact_NN on_IN the_DT optimal_JJ antibiotic_JJ management_NN of_IN CoNS_NP infections_NNS ._SENT Rapid_JJ antimicrobial_JJ susceptibility_NN testing_NN (_( RAST_NP )_) was_VBD reported_VBN to_TO have_VB an_DT important_JJ clinical_JJ impact_NN due_JJ to_TO decreased_VBN rates_NNS of_IN mortality_NN ._SENT Additionally_RB ,_, financial_JJ benefits_NNS are_VBP attributable_JJ to_TO reduced_VBN laboratory_NN pharmacy_NN and_CC other_JJ general_JJ costs_NNS ,_, which_WDT were_VBD significantly_RB lower_JJR for_IN the_DT RAST_JJ groups_NNS ._SENT Concerning_VBG CoNS_NP infections_NNS ,_, rapid_JJ and_CC reliable_JJ detection_NN of_IN methicillin_NN resistance_NN in_IN CoNS_NP is_VBZ highly_RB desirable_JJ to_TO reduce_VB the_DT overuse_NN of_IN glycopeptides_NNS for_IN the_DT treatment_NN of_IN CoNS_NP infections_NNS ._SENT Widespread_JJ use_NN of_IN glycopeptides_NNS risks_NNS increasing_VBG the_DT numbers_NNS of_IN infections_NNS caused_VBN by_IN vancomycin-resistant_JJ enterococci_NNS and_CC causing_VBG the_DT emergence_NN of_IN glycopeptide_NNS resistance_NN in_IN S._NP aureus_NN ._SENT In_IN the_DT present_JJ study_NN the_DT combination_NN of_IN the_DT VITEK_NP 2_CD OR_NN test_NN and_CC VITEK_NP 2_CD oxacillin_NN MIC_JJ determination_NN proved_VBN to_TO be_VB a_DT highly_RB sensitive_JJ ,_, specific_JJ ,_, and_CC rapid_JJ procedure_NN at_IN least_JJS equivalent_NN to_TO other_JJ phenotypic_JJ techniques_NNS for_IN the_DT detection_NN of_IN methicillin_NN resistance_NN in_IN CoNS_NP ,_, like_IN the_DT oxacillin_NN spread_NN plate_NN technique_NN ,_, the_DT method_NN with_IN oxacillin_NN disk_NN on_IN NaCl-supplemented_NP Mueller-Hinton_NP agar_NN ,_, or_CC the_DT broth_NN microdilution_NN method_NN ._SENT The_DT results_NNS of_IN our_PP$ study_NN encourage_VB the_DT use_NN of_IN the_DT VITEK_NP 2_CD system_NN for_IN the_DT detection_NN of_IN methicillin_NN resistance_NN in_IN CoNS_NP ._SENT 